Log In
BCIQ
Print this Print this
 

Brivanib (BMS-582664)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionDual inhibitor of VEGFR-2 and fibroblast growth factor (FGF) receptor 1 (FGFR1; CD331)
Molecular Target Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1) ; Fibroblast growth factor (FGF) receptor 1 (FGFR1) (CD331)
Mechanism of ActionFibroblast growth factor (FGF) receptor (FGFR) agonist; Vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) kinase inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/23/2015

Undisclosed

0

Undisclosed

Get a free BioCentury trial today